ATYPICAL ENDOMETRIAL HYPERPLASIA
Clinical trials for ATYPICAL ENDOMETRIAL HYPERPLASIA explained in plain language.
Never miss a new study
Get alerted when new ATYPICAL ENDOMETRIAL HYPERPLASIA trials appear
Sign up with your email to follow new studies for ATYPICAL ENDOMETRIAL HYPERPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common Weight-Loss drug help hormone therapy work better for young women with endometrial cancer?
Disease control Not yet recruitingThis trial tests whether adding orlistat, a weight-loss drug that blocks fat absorption, to standard progestin therapy can improve treatment response in young women (45 or younger) with early-stage endometrial cancer or atypical endometrial hyperplasia who have low progesterone r…
Matched conditions: ATYPICAL ENDOMETRIAL HYPERPLASIA
Phase: PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Can weight-loss drugs and hormones make endometrial cancer surgery safer for obese women?
Disease control Not yet recruitingThis study tests whether a 28- to 54-week program of weight-loss medication (semaglutide), a hormone-releasing IUD, diet, and exercise is safe and feasible before surgery in women with early endometrial cancer and a BMI of 40 or higher. Eighty participants will be randomly assign…
Matched conditions: ATYPICAL ENDOMETRIAL HYPERPLASIA
Phase: PHASE4 • Sponsor: Hospital Universitari de Bellvitge • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC